1.
Hayakawa S, Matsuzawa Y, Irie T, Rikitake H, Okada N, Suzuki Y. Efficacy of recombinant human soluble thrombomodulin for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a single arm, non-randomized prospective clinical trial. Multidiscip Respir Med [Internet]. 2016 Nov. 7 [cited 2025 Jun. 30];11(1). Available from: https://mail.mrmjournal.org/index.php/mrm/article/view/343